LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Invesco Ltd.'s Holding History (CIK: 0000914208)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 378,880 Value ($000) $204 Avg Close — Range —
Q4 2024
Shares 407,205 Value ($000) $261 Avg Close — Range —
Q3 2024
Shares 405,949 Value ($000) $560 Avg Close — Range —
Q2 2024
Shares 406,865 Value ($000) $590 Avg Close — Range —
Q1 2024
Shares 409,406 Value ($000) $913 Avg Close — Range —
Q4 2023
Shares 311,109 Value ($000) $604 Avg Close — Range —
Q3 2023
Shares 292,712 Value ($000) $430 Avg Close — Range —
Q2 2023
Shares 290,661 Value ($000) $924 Avg Close — Range —
Q1 2023
Shares 289,186 Value ($000) $682 Avg Close — Range —
Q4 2022
Shares 55,672 Value ($000) $193 Avg Close — Range —
Q3 2022
Shares 310,996 Value ($000) $2,280 Avg Close — Range —
Q2 2022
Shares 56,120 Value ($000) $366 Avg Close — Range —
Q1 2022
Shares 58,684 Value ($000) $296 Avg Close — Range —
Q4 2021
Shares 11,539 Value ($000) $89 Avg Close — Range —